R&J BWELL PRODUCTS Trademark

Trademark Overview

On Monday, July 20, 2020, a trademark application was filed for R&J BWELL PRODUCTS with the United States Patent and Trademark Office. The USPTO has given the R&J BWELL PRODUCTS trademark a serial number of 90061644. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, May 31, 2024. This trademark is owned by All Pharma LLC. The R&J BWELL PRODUCTS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services
r&j bwell products

General Information

Serial Number90061644
Word MarkR&J BWELL PRODUCTS
Filing DateMonday, July 20, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, May 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkR AND J BWELL PRODUCTS
Goods and ServicesPharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 21, 2021
Primary Code042
First Use Anywhere DateSunday, March 1, 2020
First Use In Commerce DateSunday, March 1, 2020

Trademark Owner History

Party NameAll Pharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMiami Lakes, FL 33016

Trademark Events

Event DateEvent Description
Thursday, July 23, 2020NEW APPLICATION ENTERED
Tuesday, November 3, 2020ASSIGNED TO EXAMINER
Monday, August 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 12, 2020NON-FINAL ACTION E-MAILED
Thursday, November 12, 2020NON-FINAL ACTION WRITTEN
Thursday, November 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 22, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 22, 2021SUSPENSION LETTER WRITTEN
Friday, January 22, 2021LETTER OF SUSPENSION E-MAILED
Monday, December 5, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, September 7, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 2, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, February 15, 2024NON-FINAL ACTION WRITTEN
Thursday, February 15, 2024NON-FINAL ACTION E-MAILED
Thursday, February 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 31, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, May 31, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, June 17, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, January 17, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Related Keywords

products bwell services development drug pharmaceutical